• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响医务人员参与囊性纤维化人群携带者筛查的因素。

Factors influencing medical practitioner participation in population carrier screening for cystic fibrosis.

机构信息

Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Clinical Genetics Service, Austin Health, Melbourne, Victoria, Australia.

出版信息

Aust N Z J Obstet Gynaecol. 2021 Apr;61(2):232-238. doi: 10.1111/ajo.13264. Epub 2020 Nov 2.

DOI:10.1111/ajo.13264
PMID:33135161
Abstract

BACKGROUND

Cystic fibrosis (CF) carrier screening should be offered to people planning a pregnancy or in early pregnancy, according to current recommendations. However, research indicates rates of offering CF carrier screening are low. Health professionals (HPs) play an important role in offering population carrier screening.

AIMS

To determine the opinions, knowledge and practice patterns of HPs with regard to the routine offering of population carrier screening for CF.

MATERIALS AND METHODS

Five key informant interviews informed the development of an online questionnaire which was distributed to a select group of HPs involved in prenatal care in Victoria, Australia.

RESULTS

Of the participants who completed the questionnaire (n = 87), 35.6% reported offering CF carrier screening to all patients attending for preconception or early pregnancy consultations. High referrers of CF carrier screening were more likely to be female, work in the private sector, in metropolitan areas and specialise as an obstetrician. High referrers demonstrated a greater level of knowledge of CF and carrier screening than low referrers (t = -3.779, P < 0.001). Low referrers perceived more barriers to offering carrier screening than high referrers (t = 2.125, P = 0.037). Low referrers were more likely to perceive lack of community awareness and HP knowledge as a barrier to offering CF carrier screening, compared to high referrers, who were more likely to perceive time constraints as a barrier.

CONCLUSIONS

To promote routine offering of population CF carrier screening, resources are needed to improve knowledge and provide clinical support thereby reducing perceived barriers.

摘要

背景

根据现行建议,应向计划怀孕或孕早期的人群提供囊性纤维化 (CF) 携带者筛查。然而,研究表明提供 CF 携带者筛查的比例较低。卫生专业人员 (HP) 在提供人群携带者筛查方面发挥着重要作用。

目的

确定 HP 对 CF 人群携带者筛查常规提供的意见、知识和实践模式。

材料和方法

对 5 名关键知情者进行访谈,为在线问卷的制定提供信息,该问卷分发给澳大利亚维多利亚州参与产前护理的精选 HP 群体。

结果

在完成问卷的参与者中(n=87),35.6%的人报告向所有参加孕前或早孕咨询的患者提供 CF 携带者筛查。CF 携带者筛查的高推荐者更有可能是女性,在私营部门工作,在大都市区工作,专门从事产科医生。高推荐者比低推荐者表现出更高的 CF 和携带者筛查知识水平(t=-3.779,P<0.001)。低推荐者比高推荐者认为提供携带者筛查的障碍更多(t=2.125,P=0.037)。与高推荐者相比,低推荐者更有可能将社区意识和 HP 知识不足视为提供 CF 携带者筛查的障碍,而高推荐者更有可能将时间限制视为障碍。

结论

为了促进 CF 人群携带者筛查的常规提供,需要资源来提高知识并提供临床支持,从而减少感知到的障碍。

相似文献

1
Factors influencing medical practitioner participation in population carrier screening for cystic fibrosis.影响医务人员参与囊性纤维化人群携带者筛查的因素。
Aust N Z J Obstet Gynaecol. 2021 Apr;61(2):232-238. doi: 10.1111/ajo.13264. Epub 2020 Nov 2.
2
Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?澳大利亚针对囊性纤维化的产前和孕前人群携带者筛查:我们进展到什么程度了?
Aust N Z J Obstet Gynaecol. 2014 Dec;54(6):503-9. doi: 10.1111/ajo.12255. Epub 2014 Oct 28.
3
Attitudes and opinions of pregnant women who are not offered cystic fibrosis carrier screening.未接受囊性纤维化携带者筛查的孕妇的态度和意见。
Eur J Hum Genet. 2014 Jul;22(7):859-65. doi: 10.1038/ejhg.2013.267. Epub 2013 Nov 20.
4
Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members.囊性纤维化患者及其家庭成员对人群囊性纤维化产前和孕前携带者筛查的看法。
Genet Test Mol Biomarkers. 2011 Mar;15(3):159-64. doi: 10.1089/gtmb.2010.0121. Epub 2011 Jan 4.
5
Cystic fibrosis carrier population screening in the primary care setting.基层医疗环境中的囊性纤维化携带者群体筛查。
Am J Hum Genet. 1996 Jul;59(1):234-47.
6
Population-based genetic screening for cystic fibrosis: attitudes and outcomes.基于人群的囊性纤维化基因筛查:态度与结果
Public Health Genomics. 2010;13(7-8):449-56. doi: 10.1159/000276544. Epub 2010 Jan 14.
7
Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands.孕前囊性纤维化携带者筛查:荷兰全科医生、妇科医生和儿科医生的观点。
Genet Test. 2004 Winter;8(4):431-6. doi: 10.1089/gte.2004.8.431.
8
Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.对囊性纤维化携带者进行全社区筛查可替代新生儿筛查来诊断囊性纤维化。
J Paediatr Child Health. 2007 Nov;43(11):721-3. doi: 10.1111/j.1440-1754.2007.01224.x.
9
'It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening.“这不在我的世界里”:对与囊性纤维化携带者筛查相关的态度和影响的探索。
Eur J Hum Genet. 2008 Apr;16(4):435-44. doi: 10.1038/sj.ejhg.5201965. Epub 2007 Dec 5.
10
Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.维多利亚州基于人群的囊性纤维化携带者筛查:头三年的经验。
Aust N Z J Obstet Gynaecol. 2009 Oct;49(5):484-9. doi: 10.1111/j.1479-828X.2009.01045.x.

引用本文的文献

1
Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.囊性纤维化、脆性 X 综合征、血红蛋白病和地中海贫血、脊髓性肌萎缩症携带者筛查计划:一项卫生技术评估。
Ont Health Technol Assess Ser. 2023 Aug 10;23(4):1-398. eCollection 2023.
2
The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation.澳大利亚生殖遗传携带者筛查项目(麦肯齐使命):设计与实施
J Pers Med. 2022 Oct 28;12(11):1781. doi: 10.3390/jpm12111781.
3
Ethical considerations in gene selection for reproductive carrier screening.
用于生殖载体筛查的基因选择中的伦理考虑因素。
Hum Genet. 2022 May;141(5):1003-1012. doi: 10.1007/s00439-021-02341-9. Epub 2021 Aug 23.
4
Health practitioners' perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic review.卫生保健从业者对实施生殖遗传携带者筛查的障碍和促进因素的看法:系统评价。
Prenat Diagn. 2021 May;41(6):708-719. doi: 10.1002/pd.5914. Epub 2021 Mar 5.